4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-23-053819
Options or other derivatives
- Chief Medical Officer acquired 16,667 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Morrow Phuong Khanh · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-13 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +16,667 | 16,667 | D |
Loading xslF345X05/ownership.xml…